QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 107 in last 24h · 178,660 total before filter · latest 1h ago

107last 24h

3127last 7d

512● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1821 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: VRTXSentiment:bullish neutral bearish show all (incl. clickbait)

Insider Monkey58d agoneutral

Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis

InvestorsHub68d agoneutral

Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform

24/7 Wall St.87d agoneutral

Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes Public

BioPharma Dive109d agoneutral

Vertex was sole bidder in high-premium Crinetics acquisition

Motley Fool112d agoneutral

Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching

Motley Fool118d agobullish

Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?

Stocktwits124d agoneutral

Crinetics Acquisition Creates A ‘Fifth Commercial Pillar’ For Vertex, Says Analyst - Why HC Wainwright Sees A 24% Upside Potential In VRTX Stock

Stocktwits125d agobullish

CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition

Investing.com125d agobullish

Crinetics soars on $10B acquisition by Vertex